发明人钱学锋,杨光,周伟. "一种达可替尼杂质30的合成方法" [P]. 中国发明专利, 专利号 CN 115732315 A, 授权公告日 2018-04-24.
发明人陈志强,李文辉,罗永刚. "Method for the Synthesis of Dacomitinib Impurity 30" [P]. 中国发明专利, 专利号 CN 115751077 B, 授权公告日 2022-04-28.
发明人郑宇鹏,李文辉,陈志强. "A Process for Preparing High-Purity Dacomitinib Impurity 30" [P]. 中国发明专利, 专利号 CN 116974564 B, 授权公告日 2016-07-20.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 达可替尼杂质30 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2022, 1014, 4482-4506.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达可替尼杂质30 as an Impurity". Anal. Chim. Acta, 2016, 307, 9881-9889.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Dacomitinib Impurity 30 Using HRMS and NMR". Environ. Sci. Technol., 2019, 930, (7), 8963-8968.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 达可替尼杂质30 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 1851, (1), 2918-2944.